Rossella Elisei
University of Pisa
249Publications
58H-index
14.2kCitations
Publications 249
Newest
Published on Mar 5, 2019in Oncotarget
Anello Marcello Poma2
Estimated H-index: 2
,
Vincenzo Condello1
Estimated H-index: 1
+ 4 AuthorsFulvio Basolo60
Estimated H-index: 60
Source Cite
Published on Jan 1, 2019in Molecular and Cellular Endocrinology 3.56
Vincenzo Condello1
Estimated H-index: 1
,
Liborio Torregrossa16
Estimated H-index: 16
+ 8 AuthorsPaolo Vitti50
Estimated H-index: 50
Abstract Follicular Variant of Papillary Thyroid Carcinoma (FVPTC) is usually associated with a good outcome. Nevertheless, in rare cases, it develops distant metastases (1–9%). Our goal was to investigate whether mRNA and miRNA expression profiles may help distinguish between metastatic versus non-metastatic FVPTCs. Twenty-four primary FVPTCs, 12 metastatic and 12 non-metastatic, with similar clinicopathological features were selected and analyzed by nanoString nCounter technology using two dis...
Source Cite
Published on Feb 1, 2019in Endocrine-related Cancer 5.33
Mimi I. Hu4
Estimated H-index: 4
,
Rossella Elisei58
Estimated H-index: 58
+ 8 AuthorsRichard Weiss
Source Cite
David Viola16
Estimated H-index: 16
,
Rossella Elisei58
Estimated H-index: 58
Source Cite
Published on Mar 1, 2019in The Lancet Diabetes & Endocrinology 19.31
Frederic Castinetti1
Estimated H-index: 1
(French Institute of Health and Medical Research),
Steven G Waguespack37
Estimated H-index: 37
(University of Texas MD Anderson Cancer Center)
+ 63 AuthorsRossella Elisei58
Estimated H-index: 58
Summary Background Multiple endocrine neoplasia type 2B is a rare syndrome caused mainly by Met918Thr germline RET mutation, and characterised by medullary thyroid carcinoma, phaeochromocytoma, and extra-endocrine features. Data are scarce on the natural history of multiple endocrine neoplasia type 2B. We aimed to advance understanding of the phenotype and natural history of multiple endocrine neoplasia type 2B, to increase awareness and improve detection. Methods This study was a retrospective,...
Source Cite
Rossella Elisei58
Estimated H-index: 58
(University of Pisa),
Antonio Matrone6
Estimated H-index: 6
(University of Pisa)
+ 12 AuthorsFrancesco Latrofa20
Estimated H-index: 20
(University of Pisa)
Source Cite
Published on Jan 4, 2018in Oncotarget
Cristina Romei35
Estimated H-index: 35
,
Raffaele Ciampi20
Estimated H-index: 20
+ 7 AuthorsRossella Elisei58
Estimated H-index: 58
// Cristina Romei 1 , Raffaele Ciampi 1 , Francesca Casella 1 , Alessia Tacito 1 , Liborio Torregrossa 2 , Clara Ugolini 2 , Fulvio Basolo 2 , Gabriele Materazzi 2 , Paolo Vitti 1 and Rossella Elisei 1 1 Endocrine Unit, Department of Clinical and Experimental Medicine, University Hospital of Pisa, Pisa, Italy 2 Department of Surgical, Medical and Molecular Pathology, University Hospital of Pisa, Pisa, Italy Correspondence to: Rossella Elisei, email: rossella.elisei@med.unipi.it Keywords: medulla...
Source Cite
Published on Apr 12, 2018in Oncology Letters 1.66
Cristina Romei35
Estimated H-index: 35
,
Alessia Tacito7
Estimated H-index: 7
+ 15 AuthorsLiborio Torregrossa16
Estimated H-index: 16
Source Cite
Published on Apr 1, 2018in Journal of the National Cancer Institute 11.24
Yueye Huang2
Estimated H-index: 2
(Tongji University),
Shen Qu4
Estimated H-index: 4
(Tongji University)
+ 18 AuthorsLaura Fugazzola35
Estimated H-index: 35
(University of Milan)
7 Citations Source Cite
12345678910